Article · Journal · 2023

Low-dose spironolactone combats dyslipidemia and hepatic inflammation by modulating PCSK9 in rat model of polycystic ovarian syndrome

Kehinde S. Olaniyi, Stephanie E. Areloegbe, Emmanuel D. Areola, Isaiah W. Sabinari, Adedamola Adediran Fafure, Richard D. Agbana and 4 more

Toxicology and Applied Pharmacology

• Closed access
• International · 2 countries

Go to the publisher10.1016/j.taap.2023.116604